Dendritic Cells (DCs) are discovered in 1973 by the Nobel Prize laureate Ralph Steinman. They are present in skin (Langerhans cells), nose, lungs, stomach, intestines.
Dendritic cells (DCs) are professional APCs that effectively prime naïve T cells and differentiate into various functional subsets. In the mucosal tissues, Dendritic Cells (DCs) are predominantly activated and migratory due to the large variety of foreign Ags and inflammatory cues
Dendritic cells (DCs) are potent antigen-presenting cells (APCs) that sample both exogenous and endogenous cues to control adaptive immunity. They play a crucial role in balancing the effector and regulatory components of the immune response.
Dendritic cells (DCs) have evolved into a variety of cell types that are distinct in their phenotype, anatomy, and function . Among these, the Conventional (or classical) Dendritic Cell 1 (cDC1) are particularly specialized in facilitating the differentiation of cytotoxic CD8+ Cytotoxic T Lymphocytes (CTLs) .
Dendritic cells (DC) initiate immune responses against pathogens while ensuring immune tolerance against self-antigens. They encompass two distinct lineages: Conventional (or classical) dendritic cells (cDCs) and Plasmacytoid Dendritic Cells (pDCs).
Interactions between dendritic cells and T cells initiate a tolerogenic or immunogenic pathway
Dendritic cells (DC) express Fc receptors for binding and internalizing antibody-antigen immune complexes.
Dendritic cells (DCs) are key antigen presenting cells that have the unique ability to present antigens on MHC molecules, which can lead to either priming or suppression of T cell mediated immune responses.
In response to danger signals and cellular stress, DCs are stimulated to mature, migrate, and carry tumor antigens to lymph nodes to alert the adaptive arm of immunity to the presence of transformed cells
Dendritic cells (DCs) sense the environment and are specialized to respond to danger signals. They are activated by this, participating in both inflammation and stimulating T cells
Dendritic cells (DCs) are crucial in the defence against pathogens. Invading pathogens are recognized by Toll-like receptors (TLRs) and receptors such as C-type lectins expressed on the surface of DCs.
Interleukin-3 (IL-3) and Granulocyte-macrophage colony-stimulating factor (GM-CSF) stimulate production of Dendritic Cells (DCs) from Bone marrow (BM) precursors
Mature DCs exhibit reduced phagocytic activity and increased expression of MHC and costimulatory molecules
Dendritic cells (DCs) are bone marrow-derived APCs (antigen presenting cells) that display unique properties aimed at stimulating naive T cells.
Dendritic cells (DCs) collect and process antigen for presentation to T cells, but there are many variations on this basic theme. DCs differ in the regulatory signals they transmit, directing T cells to different types of immune response or to tolerance.
Human DCs express several types of Fc Receptor (FCR), including CD64 (FcγRI) and CD32 (FcγRIIA / FcγRIIB)
Dendritic Cells (DCs) also dictate the development of T cell–mediated immune responses into either Type 1 immune response or Type 2 immune response
An evolutionary theory suggests that two Dendritic Cells (DCs) lineages or subsets can induce CD4+ Th1 cell responses or CD4+ Th2 Cell Responses, respectively, under certain circumstances.
Dendritic cells (DCs) prime naive T cells and to initiate primary T cell–mediated immune responses. One DC is necessary to turn on 100- 3000 T cells
Colony stimulating factor 1 (CSF1) and Granulocyte colony-stimulating factor (G-CSF) have no known effects on DCs. DCs lack mannose-fucose receptor. Dendritic cells can express the B cell-activation marker CD40 (Tumor necrosis factor receptor superfamily member 5)
DC stimulate primary human CTL in absence of CD4 T cells. They can elicit both antigen-specific cytotoxic T lymphocytes (CTLs) and nonspecific natural killer (NK) cells. The NK cell response can be depleted at the precursor level by panning with an anti-CD11b mAb. This process removes a CD11b+/CD28-, CD16+ subset from the starting CD4- responders.
Dendritic Cells (DCs), discovered by Ralph Steinman in 1973, are crucial antigen-presenting cells (APCs) found in various tissues such as skin, lungs, and intestines. They play a vital role in the immune system by priming naïve T cells and balancing effector and regulatory components of the immune response.
Functions and Characteristics
Activation and Response
Development and Regulation
Overall, dendritic cells are pivotal in initiating and regulating immune responses, making them essential for both pathogen defense and immune system balance.
see also:
Activation / Activators & Dendritic Cells (DCs)
Cancer Immunotherapy / Immuno-Oncology & Dendritic Cells (DCs)
Defending & Pathogens / Pathobionts / Pathogenic Bacteria